tetralogic pharmaceuticals c
(TLOG:Consolidated Issue listed on NASDAQ Global Market)
Mark A. McKinlay Ph.D.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Dr. Mark A. McKinlay, Ph.D. founded TetraLogic Pharmaceuticals, Inc. (formerly, Gentara Corporation) in 2003 and served as its Chief Scientific Officer and Senior Vice President of Research & Development. Dr. McKinlay founded and served as Vice President of Research and Development of ViroPharma Inc. from December 1994 to April 2004. Dr. McKinlay served as Secretary of Viropharma Inc. from December 1994 to February 1997. From 1989 to 1994, Dr. McKinlay held a variety ...
343 Phoenixville PikePhone: 610-889-9900
Malvern, Pennsylvania 19355
Board Members Memberships*There is no Board Members Memberships data available.
Rensselaer Polytechnic Institute
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|